What is the ticker symbol for Nuvalent?

Nuvalent trades under the ticker NUVL on NASDAQ.

What sector does Nuvalent operate in?

Nuvalent is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NUVL in a portfolio?

PortView shows NUVL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Nuvalent (NUVL) Stock Analysis

NASDAQHealthcareBiotechnology

$123.96+0.00%

1-year price historyRange $72.16 – $123.96

52-week range$123.96

$71.13$123.99

What Nuvalent does

Nuvalent, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering novel therapeutic solutions for individuals battling cancer. The company's pipeline features two prominent drug candidates. One of these is NVL-520, a highly selective ROS1 inhibitor capable of penetrating the brain. This compound is specifically designed to target ROS1 fusions that possess the normal ROS1 kinase domain, and crucially, it retains activity against mutations known to confer resistance to both approved and experimental ROS1 inhibitors. NVL-520 is currently undergoing Phase I clinical evaluation. Nuvalent's second key asset is NVL-655, an ALK-selective inhibitor that also exhibits brain-penetrant properties. This therapy seeks to address significant limitations of earlier generations of ALK inhibitors (first-, second-, and third-generation), including the development of treatment resistance, central nervous system-related adverse effects, and brain metastases. NVL-655 is presently being assessed in Phase I/II clinical trials. The company was established in 2017 and is based in Cambridge, Massachusetts.

Key metrics

Market cap

$9.13B

P/E (TTM)

-21.79

EPS (TTM)

$-5.69

Beta

1.14

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$112.22

200-day avg

$103.43

52-week high

$123.99

52-week low

$71.13

CEO

James R. Porter

ETFs linked to NUVL

Broad-market and Healthcare sector ETFs an investor holding Nuvalent is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NUVL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NUVL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Nuvalent?: Nuvalent trades under the ticker NUVL on NASDAQ.
Which exchange is NUVL listed on?: NUVL is listed on NASDAQ.
What sector does Nuvalent operate in?: Nuvalent is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NUVL in a portfolio?: PortView shows NUVL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.